A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya
Clinical trial NCT04826094 · COMPLETED
Trial details
- NCT number
- NCT04826094
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-15
- Primary completion
- 2024-02-13
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.